Literature DB >> 30659050

Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Marie Kostine1, Laura C Cappelli2, Cassandra Calabrese3, Leonard H Calabrese3, Clifton O Bingham2, Christophe Richez4, Jacques-Eric Gottenberg5, Olivier Lambotte6.   

Abstract

Entities:  

Keywords:  PD-1; T Cells; arthritis; autoimmunity; inflammation; multidisciplinary team-care

Year:  2019        PMID： 30659050     DOI： 10.1136/annrheumdis-2018-214748

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Knowledge gap about immune checkpoint inhibitors among rheumatologists and medical students: a survey.

Authors:  Guilherme Ferreira Maciel da Silva; Joaquim Ivo Vasques Dantas Landim; Lucas Teixeira Dos Santos Brasil; Isabella Cabral Marinho Plens; Andressa Laura Castro Silva; Morton Aaron Scheinberg; Francisco Airton Castro Rocha
Journal:  Rheumatol Int       Date:  2020-08-07       Impact factor: 2.631

Review 2.  Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.

Authors:  Sanket Shah; Debashish Danda; Chengappa Kavadichanda; Saibal Das; M B Adarsh; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2020-07-14       Impact factor: 2.631

3.  Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.

Authors:  Noha Abdel-Wahab; Maria E Suarez-Almazor
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

4.  Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Abraham Rutgers; T Jeroen N Hiltermann; Sjoukje F Oosting; Riemer H J A Slart; Elisabeth Brouwer
Journal:  Ann Rheum Dis       Date:  2020-04-02       Impact factor: 27.973
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.